2013 American Transplant Congress
Outcomes of Persistent EBV Viremia Post Transplant in Pediatric Renal Allograft Recipients: Effects of Rituximab Treatment
Post-Tx lymphoproliferative disorder (PTLD), usually caused by EBV, is a serious complication in renal Tx patients (pts), and a correlation between persistent EBV viremia (PEBV)…2013 American Transplant Congress
Protocol Biopsies Are Valuable in High Immunologic Risk Patients
Surgery, Columbia University, New York; Nephrology, Columbia University, New York
INTRODUCTION: The utility of protocol allograft biopsies (at prespecified intervals regardless of allograft function) remains unclear even in patients with elevated immunological risk such as…2013 American Transplant Congress
Serum Changes in FGF23 and Biochemical Biomarkers of Bone Mineral Disorder in Children after Renal Transplantation
Hospital Infantil de México Federico Gomez, Mexico, DF, Mexico
Successful renal transplantation improves chronic kidney disease-mineral and bone disorder in children, nevertheless several factors contribute to persistent bone disorder in transplant recipients such as…2013 American Transplant Congress
Long Term Outcomes and Quality of Life of Live Liver Donors. A Single Center Experience
Purpose: Short term outcomes of live liver donors are well described; however there are few reports on long term outcomes and quality of life (QoL).…2013 American Transplant Congress
Novel Strategy To Prevent HCV Re-Infection Post Liver Transplantation: Anti-E1/E2 Monoclonal Antibody and Epigallocatechin Gallate (EGCG) in Combination, A
University of Alberta, Edmonton, Canada
Background: Prophylaxis against HCV infection of the naÏve allograft is integral to efforts to improve outcomes in HCV positive liver transplant recipients. To effectively achieve…2013 American Transplant Congress
Validating the Microarray Test for T Cell-Mediated Rejection in Biopsies in a Prospective Trial: The INTERCOM Study
We previously reported a microarray-based test for T cell-mediated rejection (TCMR) in biopsies from renal transplants. To validate this test, we undertook a prospective international…2013 American Transplant Congress
Thromboembolic Events Are Increased in Heart and Lung Transplant Recipients Who Received Intra-Operative Recombinant Factor VIIa
Recombinant Factor VIIa (rFVIIa) is often used intra-operatively for refractory bleeding in heart and lung transplant recipients (HTxR, LTxR). While this off-label use may help…2013 American Transplant Congress
Use of Continuous Glucose Monitoring (CGM) in the Evaluation of Auto-Islet Candidates
Surgery, University of Arizona, Tucson, AZ
Purpose: We used continuous glucose monitoring (CGM) as a comparative tool with glycated hemoglobin A1c (HbA1c) to assess metabolic function in auto-islet transplant candidates.Methods: From…2013 American Transplant Congress
Impact of Socio-Demographic Variables on the Pathology on Living Kidney Donors
Purpose: Living kidney donation is the preferred therapy for kidney transplant recipients and outcomes of living donors have been overall excellent. There are no histological…2013 American Transplant Congress
Feasibility of Organ Donation on ECMO: An Analysis of Kidney and Liver Allograft Data
Introduction: ECMO has become rescue therapy for adults with overwhelming cardiac and/or respiratory failure. Despite improving outcomes, not all patients are saved, creating a new…
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 178
- Next Page »